MYeloma ALLY
Detailed App Info:
Application Description
Celgene is committed to the enhancement of the practice of medicine and is pleased to provide a resource to healthcare practitioners treating multiple myeloma. MYeloma ALLY lets you easily navigate the diagnosis, risk stratification and monitoring guidelines of the International Myeloma Working Group (IMWG) and quickly search for MM-specific clinical trials powered by clinicaltrials.gov. In the office or on the go, MYeloma ALLY is by your side.
Key Features
-Review, share and save the IMWG guidelines
-Search, share and save the MM clinical trials
MYeloma ALLY™ is a trademark of Celgene Corporation.
©2013 Celgene Corporation 10/13 US-CELG130211a
Key Features
-Review, share and save the IMWG guidelines
-Search, share and save the MM clinical trials
MYeloma ALLY™ is a trademark of Celgene Corporation.
©2013 Celgene Corporation 10/13 US-CELG130211a
Requirements
Your mobile device must have at least 5.74 MB of space to download and install MYeloma ALLY app. MYeloma ALLY is available on iTunes for $0.00
If you have any problems with installation or in-app purchase, found bugs, questions, comments about this application, you can visit the official website of Celgene Celgene Corporation at http://www.celgene.com/mobilesupport/contactus.aspx.
Copyright © 2013 Celgene Corporation
